Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition
Go back to Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition| GALMED PHARMACEUTIC (NASDAQ: GLMD) | Delayed: 0.55 +0.05 (10.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.50 | 52 Week High | $9.70 | |||
| Open | $0.48 | 52 Week Low | $2.78 | |||
| Day High | $0.56 | P/E | N/A | |||
| Day Low | $0.47 | EPS | $0.00 | |||
| Volume | 209,953 | |||||
